Abstract

The objective of this advisory committee statement is to provide guidance for the equitable, ethical, and efficient allocation of authorized COVID-19 vaccines in the context of staggered arrival of vaccine supply that will necessitate offering vaccines to some populations earlier than others. This guidance builds on the foundational framework of NACI’s preliminary guidance with updates informed by current evidence on COVID-19 and authorized COVID-19 vaccines.

Recommendation Americas Canada COVID-19 national prioritization of immunization